Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alvotech - Ordinary Shares (NQ: ALVO ) 11.94 +0.03 (+0.25%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Alvotech - Ordinary Shares < Previous 1 2 3 4 5 6 Next > EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) February 09, 2023 From Alvotech Via GlobeNewswire Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Proposed Biosimilar to Xolair® (Omalizumab) February 06, 2023 From Alvotech Via GlobeNewswire Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia January 24, 2023 From Alvotech Via GlobeNewswire Why Shares of Alvotech Jumped This Week December 08, 2022 The Icelandic biotech company has a deal to expand the reach of its Humira biosimilar in Eastern Europe. Via The Motley Fool Earnings Scheduled For March 1, 2023 March 01, 2023 Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. Via Benzinga uniQure Stock Trying To Close In On Key Technical Measure February 28, 2023 uniQure stock had its Relative Strength Rating upgraded to 79 Tuesday -- a nice improvement, but still shy of the 80-plus desired score. Via Investor's Business Daily Alvotech Announces Webcast of 2022 Full Year Financial Results at 8:00 am ET on March 2, 2023 February 27, 2023 From Alvotech Via GlobeNewswire Settlement of Alvotech Private Share Placement Completed February 10, 2023 From Alvotech Via GlobeNewswire Alvotech Completes $137 Million Private Share Placement January 23, 2023 From Alvotech Via GlobeNewswire Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate January 13, 2023 From Alvotech Via GlobeNewswire Alvotech Initiates Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria® January 11, 2023 From Alvotech Via GlobeNewswire Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) January 06, 2023 From Teva Pharmaceutical Industries Limited Via Business Wire Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) January 06, 2023 From Alvotech Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session December 22, 2022 Via Benzinga Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session December 22, 2022 Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. Via Benzinga MillerKnoll, Cleveland-Cliffs And Some Other Big Stocks Moving Higher On Thursday December 22, 2022 U.S. stocks traded lower, with the Dow Jones dropping over 400 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 22, 2022 Via Benzinga Update on U.S. Regulatory Status of AVT02, Alvotech’s Proposed High-Concentration, Interchangeable Biosimilar to Humira® December 22, 2022 From Alvotech Via GlobeNewswire Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT to headline field December 16, 2022 From Alvotech Via GlobeNewswire Alvotech Completes $59.7 Million Private Placement December 16, 2022 From Alvotech Via GlobeNewswire Alvotech Shares Start Trading on Nasdaq Iceland Main Market December 08, 2022 From Alvotech Via GlobeNewswire Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session December 07, 2022 Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... Via Benzinga Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe December 07, 2022 From Alvotech Via GlobeNewswire Alvotech Announces Changes to its Leadership Team December 01, 2022 From Alvotech Via GlobeNewswire Alvotech Secures Financing Facilities of Approximately $136 Million November 16, 2022 From Alvotech Via GlobeNewswire Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update November 16, 2022 From Alvotech Via GlobeNewswire Earnings Scheduled For November 15, 2022 November 15, 2022 Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million. Via Benzinga Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira® November 14, 2022 From Alvotech Via GlobeNewswire Alvotech to Present Switching Study Data for AVT02, a Proposed Biosimilar to Humira®, at 2022 American College of Rheumatology Conference November 10, 2022 From Alvotech Via GlobeNewswire Alvotech to Report First Nine Months Financial Results on November 15, 2022 and Host Business Update Conference Call at 8:00 am ET on November 16, 2022 October 27, 2022 From Alvotech Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.